Back HIV/AIDS HIV/AIDS Topics HIV-Related Conditions

CROI 2013: Retrovirus Conference Starts Sunday in Atlanta

The 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) kicks off Sunday, March 3, at the Georgia World Congress Center in Atlanta. HIVandHepatitis.com will be on site next week to bring you breaking news coverage on HIV and hepatitis C.

Look for reports from the HIVandHepatitis.com team and our content partners at NAM/Aidsmap.com starting Monday. Sign up for our email newsletter to get the latest headlines and follow us on Twitter @HIVandHepatitis.alt

Read more:

HIV Infection May Raise Risk of Sudden Hearing Loss

Young HIV positive people age 18 to 35 had more than twice the likelihood of sudden sensorineural hearing loss compared with their HIV negative counterparts, according to an analysis of nearly 9000 people with HIV described in the February 21, 2013, advance online edition of JAMA Otolaryngology-Head & Neck Surgery.

alt

Read more:

FDA Approves Diarrhea Drug Crofelemer for People with HIV/AIDS

On December 31, the U.S. Food and Drug Administration (FDA) approved crofelemer (brand name Fulyzaq) for treatment of diarrhea in people with HIV/AIDS on antiretroviral therapy (ART) -- the first approved medication for this indication.

alt

Read more:

People with HIV Have Higher Rates of Non-AIDS Malignancies, Skin Cancer

The incidence of non-AIDS-defining cancers has increased among people with HIV in the era of effective antiretroviral treatment, including malignancies caused by viruses such as human papillomavirus (HPV), and squamous cell non-melanoma skin cancer, according to 2 recently published studies.alt

Read more:

Working Group Releases Guidelines for Improved Care of HIV-associated Cognitive Impairment

All people with HIV should be screened for HIV-associated neurocognitive disorders soon after testing positive, and those with evidence of impairment should be monitored regularly, according to international consensus guidelines developed by the Mind Exchange Working Group published in the November 28, 2012, advance edition of Clinical Infectious Diseases. Beyond antiretroviral therapy (ART), however, there are limited options for managing neurocognitive problems.

alt

Read more:

HIV Treatment Interruption Associated with Reduced Bone Loss in SMART Trial

People who stopped antiretroviral therapy (ART) in the SMART trial had less bone loss and lower levels of bone metabolism biomarkers than people who remained on continuous treatment, according to a report in the January 8, 2013, advance edition of Journal of Bone Mineral Research.

alt

Read more:

Coverage of 11th International Congress on Drug Therapy in HIV Infection

HIVandHepatitis.com coverage of the 11th International Congress on Drug Therapy in HIV Infection (HIV11), November 11-15, 2012, Glasgow, Scotland.

Conference highlights include experimental antiretroviral drugs, ART strategies, manging side effects, HIV-related non-AIDS conditions, treatment as prevention and PrEP, HIV/HCV coinfection, and the search for a cure for HIV.

Full listing by topic

HIVandHepatitis.com HIV11 conference section

11/17/12

alt

Higher Dose Flu Vaccine Works Better for People with HIV

HIV positive people who received a quadruple dose of a trivalent seasonal influenza vaccine produced more protective antibodies without a significant increase in side effects, researchers reported in the January 1, 2013, Annals of Internal Medicine.
alt

Read more:

Speed of Processing Training Can Improve Cognitive Function for People with HIV

Completing 10 hours of exercises designed to enhance mental processing speed led to improvements in cognitive functioning for middle-aged and older people with HIV and increased their ability to carry out daily tasks, researchers reported in the November 2012 Journal of the Association of Nurses in AIDS Care.  alt

Read more: